A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.

Martin T King,David D Yang,Vinayak Muralidhar,Brandon Mahal,Santino Butler,Phillip M Devlin,Larissa J Lee,Kent W Mouw,Neil M Martin,Anthony V D'Amico,Paul L Nguyen,Peter F Orio

Brachytherapy（2019）

引用 16|浏览26

暂无评分

摘要

Our results suggest that HDR brachytherapy boost yields similar OS benefits compared with LDR brachytherapy boost for unfavorable-risk prostate cancer. HDR boost may be a suitable alternative to LDR boost.

查看译文

关键词

Low-dose-rate brachytherapy,High-dose-rate brachytherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要